Fulvestrant vs Orserdu: Side-by-Side Comparison
Quick answer: Fulvestrant and Orserdu are both selective estrogen receptor degrader (serd) used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Fulvestrant | Orserdu |
|---|---|---|
| Drug class | Selective estrogen receptor degrader (SERD) | Selective estrogen receptor degrader (SERD) |
| ATC code | L02BA03 | L02BA03 |
| Primary indications | Hormone receptor-positive metastatic breast cancer | ER+/HER2-negative, ESR1-mutated advanced or metastatic breast cancer |
| Mechanism | Estrogen receptor antagonist that binds, blocks, and degrades the receptor in breast cancer cells | Oral selective estrogen receptor degrader that binds and degrades the estrogen receptor in ESR1-mutant breast cancer |
| Common dose | 500 mg IM on days 1, 15, 29, then monthly | 345 mg once daily |
| Detail page | Fulvestrant details → | Orserdu details → |
How to choose between Fulvestrant and Orserdu
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Selective estrogen receptor degrader (SERD) on iMedic · Fulvestrant full details · Orserdu full details
Frequently asked questions
Is Fulvestrant better than Orserdu?
Neither is universally 'better.' They are both selective estrogen receptor degrader (serd) with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Fulvestrant to Orserdu?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Fulvestrant and Orserdu have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Fulvestrant and Orserdu available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.